Literature DB >> 12574200

Prolactin expression and secretion by human breast glandular and adipose tissue explants.

Michael Zinger1, Molly McFarland, Nira Ben-Jonathan.   

Abstract

Prolactin (PRL) is a 23-kDa hormone produced by the pituitary and extrapituitary sites. The main target of PRL is the breast, where it affects cellular growth, differentiation, and milk production. Recent evidence suggests that locally produced PRL plays a role in breast tumorigenesis. Our objective was to examine PRL synthesis/release in different tissues of the human breast and determine the effect of ovarian steroids. Breast tissue, obtained from women undergoing mastectomy or breast reduction, was separated into glandular (nonmalignant) and adipose explants and incubated for 10 d. Conditioned media were analyzed for PRL by a bioassay. PRL release from glandular explants decreased by 60% from d 1-3, followed by a 4-fold increase on d 10. PRL release from adipose explants was unchanged from d 1-3 and increased more than 10-fold by d 10. PRL gene expression, determined by RT-PCR, was low on d 0 and markedly increased on d 10 in both types of explants. De novo synthesis of PRL was confirmed by metabolic labeling. Progesterone suppressed PRL release from glandular explants without affecting adipose explants. Estradiol did not alter PRL release from either tissue. In conclusion, the human breast produces and releases bioactive PRL, with a higher release rate by adipose than glandular tissue. The time-dependent rise in PRL release suggests removal from inhibitory control. Progesterone may be one of the factors that suppresses PRL production in the glandular compartment, whereas the factor(s) that regulate adipose PRL are unknown. These data suggest an autocrine/paracrine role for PRL in human glandular and adipose breast tissue.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574200     DOI: 10.1210/jc.2002-021255

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  31 in total

Review 1.  Extrapituitary production of anterior pituitary hormones: an overview.

Authors:  S Harvey; C Arámburo; E J Sanders
Journal:  Endocrine       Date:  2011-11-15       Impact factor: 3.633

2.  Lactogens and estrogens in breast cancer chemoresistance.

Authors:  Gila Idelman; Eric M Jacobson; Traci R Tuttle; Nira Ben-Jonathan
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

Review 3.  Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions.

Authors:  Robert J Marano; Nira Ben-Jonathan
Journal:  Mol Endocrinol       Date:  2014-04-02

Review 4.  Anatomical, Physiological, and Functional Diversity of Adipose Tissue.

Authors:  Rachel K Zwick; Christian F Guerrero-Juarez; Valerie Horsley; Maksim V Plikus
Journal:  Cell Metab       Date:  2018-01-09       Impact factor: 27.287

5.  Estrogen-like disruptive effects of dietary exposure to bisphenol A or 17α-ethinyl estradiol in CD1 mice.

Authors:  Eric L Kendig; Dana R Buesing; Susie M Christie; Clifford J Cookman; Robin B Gear; Eric R Hugo; Susan N Kasper; Jessica A Kendziorski; Kevin R Ungi; Karin Williams; Scott M Belcher
Journal:  Int J Toxicol       Date:  2012-11-15       Impact factor: 2.032

6.  Body condition of late pregnant gilts affects the expression of selected adipokines and their receptors in mammary fat and backfat tissues.

Authors:  Cristiane R A Duarte; Chantal Farmer; Marie-France Palin
Journal:  J Anim Sci       Date:  2019-01-01       Impact factor: 3.159

Review 7.  Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review.

Authors:  Harsh Patel; Victor Arruarana; Lucille Yao; Xiaojiang Cui; Edward Ray
Journal:  Endocrine       Date:  2020-02-17       Impact factor: 3.633

Review 8.  Rational design of competitive prolactin/growth hormone receptor antagonists.

Authors:  Estelle Tallet; Vincent Rouet; Jean-Baptiste Jomain; Paul A Kelly; Sophie Bernichtein; Vincent Goffin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

9.  Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.

Authors:  Lisa M Arendt; Lindsay C Evans; Debra E Rugowski; Maria Jose Garcia-Barchino; Hallgeir Rui; Linda A Schuler
Journal:  J Endocrinol       Date:  2009-07-27       Impact factor: 4.286

10.  Revisiting influences on tumor development focusing on laboratory housing.

Authors:  Helaine M Alessio; Natalie B Schweitzer; Angela M Snedden; Phyllis Callahan; Ann E Hagerman
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-05       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.